Adesso SE (ADN1)

Marketing approval is good for cancer vaccines.

$AXP.ax $AUNXF secured transformational farm-in to earn up to 25% in Syria’s Block 9 PSC in Palmyride Basin, positioning AXP Energy for early exposure to re-opening Middle East energy sector following sanctions relief & renewed investment interest.

https://x.com/axp_energy/status/2066

Valumind- I give up, which one ?

Congrats

In reality Biel PPS is in freeze position. Monday morning trades will show that, and you will look like a howling pump monkey.

Happy trading, see you at .0001

My point of view is that Eliquis will not be sold by elite but by the company that will buy elite. No one knows what will be the market value of Eliquis in 1.2 or 5 years from now because we don’t know if Pfizer will play ball like Purdue or play fair.

The pr says 26 billion let the

So on LinkedIn 2 people from Parker Institute for Cancer Immunotherapy will be on the Today show talking about "Breast Cancer Vaccine Latest with Kristen Dahlgren and Dr. Karen Knudsen". That is the same group who held the cancer vaccine breakfast on capital hill a week and a half ago. Time frame

"NVIDIA acts as a distributor for QNX" 😂

https://investorshub.advfn.com/uimage/uploads/2026/6/14/sxrjfBB_Nvidia_a_DISTRIBUTOR_lol_061426.png

The THOR 🏆️ QNX Market (Monopolization)

https://investorshub.advfn.com/uimage/uploads/2026/6/4/bzv

Wow!! 362,000 reads in last 24 hours for a scam stock is truly amazing!!

You omitted 10 year survival data, tax savings, higher reimbursement rates, and other nuggets you were pumping last year. Any update on those pieces?

By the way, Dr. Jenkins is kind of small league now. The companies she sits on board over the last many years are all struggling w

Goal posts were moved and endpoints were changed multiple times. The reviewers at the EMA were unconvinced. That is how we know.

Large, well designed Phase 3 trials are a must.

Live in denial if it makes you feel better.

https://www.youtube.com/watch?v=DAcHulzp6SA

Elite finance - the base wonder of the world.

We would all be well served to be conservative in our estimates and then be surprised to the upside. That’s not bashing, it’s just realism. Vyvanse was pegged as a 5.1B market and though Elite doesn’t break out revenues by product, we clearly are at a small fraction of that in *total* revenues, Vyva

Agreed, 90% or so are paid pumpers with multiple IDs. Their job is to defend managements lies and poor performance at all cost. Who cares about losing money and opportunity cost, LOL! ;)

Will it be another short ~2 years? only the traders, and fake longs (shorts- you?), care about the week-to-week. Longs are looking forward to 2027+.

5 natural fertilizers that work Instantly

When perceived dead plants

www.youtube.com/watch?v=RUtAxDdT0zY Come back to life

https://www.youtube.com/watch?v=RUtAxDdT0zY (27:03)

Worth the watch

For gardeners

Would it not be more reasonable to gauge value from the relative pricing endpoint than the temporary higher generic entry pricing? Emphasis on temporary.

🟩 Why investors care: VeeMost is building what CDW doesn’t have
CDW wins today because of:

15,000 employees

massive sales teams

decades of relationships

brute-force manpower

But CDW does not have:

If Today's war News real?

Market will be sell the news all priced.

Let see 30m charts will tell the story..

All major Index Futures are up HUGE.

Big volume in Aussieland out the gate and greeeen!

Hi kayak sorry for that one I did not remember your position on jour’s minimization on Eliquis.

🔥 Investor Critical Summary: Why VeeMost Matters Right Now

➡️️ The synergistic platforms create a flywheel CDW does NOT have
Melvin is expanding capabilities across three interconnected platforms:

A. VeeBids (AI bid discovery + automation)
Find